At the 2026 ASTCT Gene Therapy Summit, experts highlighted how chronic pain, psychological challenges, and neurologic complications may persist despite successful treatment.
|Articles|July 6, 2022
Daily OTC Pearl: Legatrin PM
Author(s)Saro Arakelians, PharmD
Legatrin PM is intended for relief of lower body pain.
Advertisement
OTC/Lifestyle Pearl of the Day: Legatrin PM
Indication: Legatrin PM is intended for relief of lower body pain.
Insight:
- Active Ingredients (per Caplet): Acetaminophen (500 mg), diphenhydramine HCl (50 mg). Inactive ingredients: croscarmellose sodium, D&C red No. 27 lake, dicalcium phosphate, FD&C blue no. 1 lake, FD&C red no. 40 lake, FD&C yellow no. 6 lake, hydroxypropyl methylcellulose, magnesium silicate, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, stearic acid, titanium dioxide.
- Directions: Adults and children 12 years of age and older: 1 caplet at bedtime or as directed by a physician. Do not give to children under the age of 12 years unless directed by your physician. Do not exceed recommended dosage. Store at room temperature.
- Consult a physician before use if you have glaucoma; breathing problems such as asthma, emphysema, chronic bronchitis or pulmonary disease; trouble urinating due to an enlarged prostate gland.
Advertisement
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
If gene therapies are expected to deliver decades of benefit, long-term evidence collection must be coordinated, useful to patients, and financially sustainable.
As kratom questions increase, many pharmacists and other health care professionals may remain unfamiliar it and the potential risks.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
3
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
4
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
5